| Literature DB >> 34934126 |
Nijole Kazukauskiene1, Aurelija Podlipskyte2, Giedrius Varoneckas2, Narseta Mickuviene2.
Abstract
The aim of the study was to investigate the association between insulin resistance (IR) and health-related quality of life (HRQoL) among citizens of Palanga in a 10-year follow-up. A randomized epidemiological study was performed with 835 subjects. The following data were examined using questionnaires: sociodemographic characteristics, behavioural factors, HRQoL and self-perceived health. Fasting blood samples were drawn from all participants, and biochemical tests were performed for glucose and insulin. IR was evaluated by the homeostasis model assessment of IR (HOMA-IR). In subjects with IR, after adjusting for various factors, logistic regression analysis showed that within 10 years, there was a significantly higher chance of deteriorating HRQoL in the areas of physical functioning (odds ratio [OR] = 1.15, p < 0.001), emotional role limitations (OR = 1.07, p = 0.034), social functioning (OR = 1.26, p = 0.004), pain (OR = 1.09, p = 0.005) and general health perception (OR = 1.07, p = 0.022). People with IR have a worse HRQoL, and as they age, they are significantly more likely to have a deterioration in their HRQoL than people without IR in the areas of physical functioning, emotional role limitations, social functioning, pain and general health perception.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34934126 PMCID: PMC8692503 DOI: 10.1038/s41598-021-03791-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The sociodemographic characteristics of subject groups without and with insulin resistance in the survey in 2003 and 2013.
| Baseline characteristics | 2003 | 2013 | 2003:2013 | 2003:2013 | ||||
|---|---|---|---|---|---|---|---|---|
| Without IR group | With IR group | p-value | Without IR group | With IR group | p-value | Without IR group | With IR group | |
| n = 557 | n = 278 | n = 557 | n = 278 | |||||
| Age, years; mean ± SD | 53.1 ± 10.6 | 54.9 ± 9.9 | 63.0 ± 10.5 | 64.8 ± 9.7 | ||||
| – | – | |||||||
| Male | 181 (32.5) | 119 (42.8) | 181 (32.5) | 119 (42.8) | ||||
| Female | 376 (67.5) | 159 (57.2) | 376 (67.5) | 159 (57.2) | ||||
| BMI, kg/m2; mean ± SD | 26.0 ± 4.3 | 30.0 ± 4.5 | 26.6 ± 4.1 | 31.0 ± 4.7 | ||||
| 0.932 | 0.533 | |||||||
| Married | 420 (75.4) | 211 (75.9) | 376 (67.5) | 181 (65.1) | ||||
| Alone | 137 (24.6) | 67 (24.1) | 181 (32.5) | 97 (34.9) | ||||
| 0.287 | 0.839 | |||||||
| Less than higher | 369 (66.2) | 217 (78.1) | 351 (63.0) | 214 (77.0) | ||||
| Higher | 188 (33.8) | 61 (21.9) | 206 (37.0) | 64 (23.0) | ||||
| 0.281 | 0.142 | |||||||
| Employed | 369(66.2) | 173 (62.2) | 277 (49.7) | 123 (44.2) | ||||
| No employed | 188 (33.8) | 105 (38.8) | 280 (50.3) | 155 (55.8) | ||||
| 0.083 | 0.277 | |||||||
| Good health | 178 (32.1) | 63 (22.7) | 203 (36.4) | 76 (27.3) | ||||
| Moderate | 344 (62.0) | 192 (69.1) | 334 (60.0) | 186 (66.9) | ||||
| Poor health | 33 (5.9) | 23 (8.3) | 20 (3.6) | 16 (5.8) | ||||
| Smoking regular; n (%) | 198 (35.5) | 112 (40.3) | 0.182 | 85 (15.3) | 38 (13.7) | 0.541 | ||
| Physical activity; n (%) | < 0.001 | < 0.001 | ||||||
| Daily walking in minutes > 60 min | 206 (37.0) | 93 (33.6) | 0.316 | 412 (73.1) | 184 (64.8) | 0.015 | ||
| SBP, mm Hg; mean ± SD | 120 ± 17.0 | 127 ± 16.0 | 128 ± 12.9 | 132 ± 12.5 | ||||
| DBP, mm Hg; mean ± SD | 81.9 ± 7.2 | 86.68 ± 9.4 | 74.0 ± 7.2 | 75.7 ± 7.4 | ||||
BMI body mass index, IR insulin resistance, SBP systolic blood pressure, DBP diastolic blood pressure; p-value of probability for comparison between groups (bolded numbers indicate significant differences, p < 0.05); data presented as n (%), mean ± SD.
Health-related quality of life scores of subject groups without and with insulin resistance in the survey in 2003 and 2013.
| SF-36 domain scores, mean (95% CI) | 2003 | 2013 | 2003:2013 | 2003:2013 | ||||
|---|---|---|---|---|---|---|---|---|
| Without IR | With IR | p-value | Without IR | With IR | p-value | Without IR | With IR | |
| n = 557 | n = 278 | n = 557 | n = 278 | |||||
| Physical functioning | 78.5 (77.1–79.9) | 75.5 (73.6–77.3) | 75.4 (73.6–77.1) | 65.4 (62.5–68.3) | ||||
| Physical role limitations | 66.9 (64.2–69.5) | 64.9 (61.3–68.4) | 0.388 | 60.5 (57.3–63.7) | 53.2 (48.4–58.0) | |||
| Emotional role limitations | 67.4 (64.7–70.1) | 69.0 (61.3–68.4) | 0.480 | 66.6 (63.4–69.9) | 64.8 (60.0–69.5) | 0.515 | 0.687 | 0.125 |
| Social functioning | 75.4 (73.9–77.0) | 75.4 (73.3–77.6) | 0.998 | 76.5 (74.6–78.4) | 69.7 (66.8–72.7) | 0.304 | ||
| Mental health | 64.4 (63.0–65.8) | 66.3 (64.7–67.9) | 0.079 | 68.6 (67.1–70.0) | 68.4 (66.–70.5) | 0.911 | ||
| Energy vitality | 60.3 (58.9–61.7) | 61.1 (59.4–62.8) | 0.477 | 61.5 (60.0–63.0) | 60.0 (57.8–62.2) | 0.254 | 0.147 | 0.351 |
| Pain | 68.7 67.1–70.4) | 67.8 (65.6–70.1) | 0.516 | 69.3 (67.3–71.2) | 65.2 (62.3–68.1) | 0.636 | 0.093 | |
| General health perception | 50.0 (48.8–51.2) | 49.3 (47.9–50.8) | 0.504 | 52.5 (51.1–53.9) | 49.2 (47.2–51.1) | 0.860 | ||
IR insulin resistance p-value of probability for comparison between groups (bolded numbers indicate significant differences, p < 0.05).
Change in health-related quality of life scores of subject groups without and with insulin resistance in the period from 2003 until 2013.
| SF-36 domain scores, mean (95% CI) | Without IR | With IR | p-value |
|---|---|---|---|
| ΔPhysical functioning | –3.1 (–4.7 to –1.6) | –10.1 (–12.9 to –7.2) | |
| ΔPhysical role limitations | –6.4 (–9.8 to –2.9) | –11.6 (–17.0 to –6.3) | 0.092 |
| ΔEmotional role limitations | –0.75 (–4.4 to 2.9) | –4.3 (–9.7 to 1.2) | 0.283 |
| ΔSocial functioning | 1.1 (–0.98 to 3.1) | –5.7 (–8.9 to –2.5) | |
| ΔMental health | 4.2 (2.6 to 5.8) | 2.1 (–0.04 to 4.3) | 0.132 |
| ΔEnergy vitality | 1.2 (–0.43 to 2.9) | –1.1 (–3.5 to 1.2) | 0.110 |
| ΔPain | 0.51 (1.6 to 2.6) | –2.6 (–2.5 to –0.01) | 0.098 |
| ΔGeneral health perception | 2.5 (1.2 to 3.8) | –0.19 (–2.3 to 1.9) |
IR insulin resistance, SF-36 The 36-item Short Form Medical Outcome Questionnaire; p-value of probability for comparison between groups (bolded numbers indicate significant differences, p < 0.05).
Results from regression analyses in which year, sex, age, and insulin resistance are regressed on SF-36 subscales.
| Independent variable | Model 1 OR (95% CI) | p-value | Model 2 OR (95% CI) | p-value | ||
|---|---|---|---|---|---|---|
| Time: 2013(1)/2003(2) | 1.65 | (1.32–2.06) | 1.64 | (1.30–2.08) | ||
| Sex: Males (1)/Females (2) | 1.29 | (1.04–1.59) | 1.22 | (0.96–1.54) | 0.104 | |
| Age | 1.04 | (1.04–1.06) | 1.04 | (1.02–1.05) | ||
| IR without (1)/with (2) | 1.36 | (1.10–1.68) | 1.15 | (1.07–1.23) | ||
| Time: 2013(1)/2003(2) | 1.56 | (1.25–1.95) | 1.53 | (1.20–1.94) | ||
| Sex: Males (1)/Females (2) | 1.32 | (1.07–1.63) | 1.15 | (0.91–1.46) | ||
| Age | 1.05 | (1.04–1.06) | 1.04 | (1.02–1.05) | ||
| IR without (1)/with (2) | 1.17 | (0.95–1.45) | 0.150 | 1.04 | (0.82–1.44) | 0.253 |
| Time: 2013(1)/2003(2) | 1.43 | (1.14–1.79) | 1.47 | (1.15–1.87) | ||
| Sex: Males (1)/Females (2) | 1.09 | (0.88–1.45) | 0.427 | 1.07 | (0.84–1.36) | 0.600 |
| Age | 1.04 | (1.03–1.05) | 1.03 | (1.02–1.05) | ||
| IR without (1)/with (2) | 1.11 | (0.90–1.38) | 0.332 | 1.07 | (1.01–1.38) | |
| Time: 2013(1)/2003(2) | 1.40 | (1.37–2.10) | 1.43 | (1.13–1.82) | ||
| Sex: Males (1)/Females (2) | 1.55 | (1.26–1.92) | 1.47 | (1.16–1.87) | ||
| Age | 1.04 | (1.03–1.05) | 1.03 | (1.02–1.05) | ||
| IR without (1)/with (2) | 1.70 | (1.37–2.10) | 1.26 | (1.03–1.17) | ||
| Time: 2013(1)/2003(2) | 0.95 | (0.76–1.18) | 0.629 | 0.98 | (0.78–1.23) | 0.933 |
| Sex: Males (1)/Females (2) | 1.09 | (0.89–1.34) | 0.408 | 1.03 | (0.82–1.29) | 0.822 |
| Age | 0.99 | (0.99–1.00) | 0.262 | 1.00 | (0.98–1.01) | 0.711 |
| IR without (1)/with (2) | 1.32 | (1.07–1.63) | 1.06 | (0.99–1.23) | 0.054 | |
| Time: 2013(1)/2003(2) | 1.13 | (0.91–1.40) | 0.273 | 1.12 | (0.97–1.53) | 0.107 |
| Sex: Males (1)/Females (2) | 1.11 | (0.91–1.36) | 0.316 | 0.97 | (0.77–1.22) | 0.801 |
| Age | 1.01 | (1.00–1.02) | 1.01 | (0.99–1.02) | 0.386 | |
| IR without (1)/with (2) | 1.40 | (1.14–1.71) | 1.03 | (0.97–1.09) | 0.370 | |
| Time: 2013(1)/2003(2) | 1.14 | (0.92–1.42) | 0.223 | 1.09 | (0.97–1.57) | 0.101 |
| Sex: Males (1)/Females (2) | 1.45 | (1.18–1.78) | 1.43 | (1.13–1.80) | ||
| Age | 1.01 | (1.00–1.02) | 1.01 | (0.99–1.02) | 0.327 | |
| IR without (1)/with (2) | 1.28 | (1.04–1.58) | 1.09 | (1.03–1.16) | ||
| Time: 2013(1)/2003(2) | 1.08 | (0.87–1.35) | 0.465 | 1.04 | (0.81–1.30) | 0.297 |
| Sex: Males (1)/Females (2) | 1.30 | (1.06–1.60) | 1.21 | (0.96–1.53) | 0.106 | |
| Age | 1.01 | (0.99–1.02) | 0.090 | 1.00 | (0.98–1.01) | 0.580 |
| IR without (1)/with (2) | 1.40 | (1.13–1.72) | 1.07 | (1.01–1.14) | ||
IR insulin resistance, OR odds ratio, CI confidence interval.
Model 1—Adjusted for year, sex, age, insulin resistance.
Model 2—Adjusted for year, sex, age, insulin resistance, marital status, education, employment, self-perceived health, frequent stressful events, depressed mood, alcohol use, smoking, illness during past 12 months, body mass index. Bolded numbers indicate significant p < 0.05.